216: Detection of chromosome abnormalities by sequential screening with first and second trimester serum and nuchal translucency - 19/12/14
Doi : 10.1016/j.ajog.2014.10.262
Rebecca Baer 1, Monica Flessel 1, Laura Jelliffe-Pawlowski 1, Sara Goldman 1, Louanne Hudgins 2, Andrew Hull 3, Mary Norton 4, Robert Currier 1
1 California Department of Public Health, Genetic Disease Screening Program, Richmond, CA
2 Stanford University, Division of Medical Genetics, Stanford, CA
3 University of California San Diego, Center for Maternal-Fetal Care & Genetics, San Diego, CA
4 University of California, San Francisco, Department of Obstetrics, Gynecology and Reproductive Sciences, San Francisco, CA
Le texte complet de cet article est disponible en PDF.
Plan
© 2015
Publié par Elsevier Masson SAS.
Vol 212 - N° 1S
P. S121-S122 - janvier 2015 Retour au numéro
Article précédent
- 215: Outcomes of pregnancies with more than one positive prenatal screening result
- Rebecca Baer, Robert Currier, Mary Norton, Monica Flessel, Sara Goldman, Dena Towner, Laura Jelliffe-Pawlowski
- 217: Amniocentesis and CVS skill as measured by reinsertion rates: is annual provider volume a factor?
- Robert Currier, Sara Goldman, Amen Ness, Manuel Porto, Cheryl Ikeda, Jamie Matteson, Mary Norton
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?